Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
difficulty swallowing
Pharma
Azurity bags FDA nod for grape-flavored multiple sclerosis drug
Weeks after Saol won approval for its strawberry-flavored oral granules, Azurity has received FDA authorization for a rival oral suspension.
Nick Paul Taylor
Feb 8, 2022 9:35am
FDA approves oral pellet version of Gilead's Epclusa
Jun 15, 2021 8:15am
FDA approves Chimerix's oral suspension smallpox antiviral
Jun 8, 2021 7:30am
Sun steps up promotion of alternative-formulation products
Mar 2, 2021 9:10am